BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 5.08.2004

Agency Emergency Processing Under Office of Management and Budget Review; Experimental Study of Petitioned Health Claims on Glucosamine and Chondroitin Sulfate; Withdrawal

The Food and Drug Administration (FDA) is withdrawing a notice that published in the Federal Register of June 3, 2004 (69 FR 31395).

Source: Federal Register — Food and Drug AdministrationOpen original release →